Seeing Is Believing
URGN is currently covered by 4 analysts with an average price target of $29.35. This is a potential upside of $15.14 (106.54%) from yesterday's end of day stock price of $14.21.
UroGen Pharma Ltd's activity chart (see below) currently has 52 price targets and 45 ratings on display. The stock rating distribution of URGN is 94.12% BUY and 5.88% HOLD.
Analysts average stock forecasts to be materialized ratio is 22.04% with an average time for these price targets to be met of 50.4 days.
Highest price target for URGN is $54, Lowest price target is $18, average price target is $29.35.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Apr-2024. First documented stock forecast 30-May-2017.
Currently out of the existing stock ratings of URGN, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
54
$39.63 (275.78%)
54
6 days ago
0/16 (0%)
$39.74 (278.68%)
Buy
35
$20.63 (143.56%)
32
3 months ago
1/13 (7.69%)
$19.96 (132.71%)
74
Hold
18
$3.63 (25.26%)
11
8 months 24 days ago
3/8 (37.5%)
$-3.66 (-16.90%)
80
Buy
10
$-4.37 (-30.41%)
45
1 years 2 months 16 days ago
1/4 (25%)
$0.86 (9.41%)
9
Buy
41
$26.63 (185.32%)
70
4 years 6 months 3 days ago
2/5 (40%)
$18.82 (84.85%)
89
What is URGN (UroGen Pharma Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on URGN (UroGen Pharma Ltd) with a proven track record?
Which analyst has the current lower performing score on URGN (UroGen Pharma Ltd) with a proven track record?
Which analyst has the most public recommendations on URGN (UroGen Pharma Ltd)?
Which analyst is the currently most bullish on URGN (UroGen Pharma Ltd)?
Which analyst is the currently most reserved on URGN (UroGen Pharma Ltd)?